Does the metabolic syndrome add to the diagnosis and treatment of cardiovascular disease? (Q37200538)

18 August 2017

1 reference

title

Does the metabolic syndrome add to the diagnosis and treatment of cardiovascular disease? (English)

1 reference

18 August 2017

0 references

1 reference

cardiovascular disease

1 reference

Dick de Zeeuw

1

1 reference

PubMed ID

18580860

18 August 2017

Stephan Jl Bakker

series ordinal

2

1 reference

18 August 2017

1 July 2008

1 reference

Nature Clinical Practice Cardiovascular Medicine

18 August 2017

1 reference

18 August 2017

5 Suppl 1

1 reference

18 August 2017

S10-4

1 reference

Banting lecture 1988. Role of insulin resistance in human disease

18 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1271

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1271

7 January 2021

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1271

7 January 2021

The metabolic syndrome--a new worldwide definition

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1271

7 January 2021

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1271

7 January 2021

Point: the metabolic syndrome still lives

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1271

7 January 2021

The metabolic syndrome: a call to action

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1271

7 January 2021

The "metabolically-obese," normal-weight individual.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1271

7 January 2021

Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1271

7 January 2021

The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1271

7 January 2021

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1271

7 January 2021

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1271

7 January 2021

Framingham score and microalbuminuria: combined future targets for primary prevention?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1271

7 January 2021

Effects of mismodelling and mismeasuring explanatory variables on tests of their association with a response variable.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1271

7 January 2021

Dichotomizing continuous predictors in multiple regression: a bad idea

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1271

7 January 2021

Cardiovascular disease risk profiles.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1271

7 January 2021

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1271

7 January 2021

Metabolic syndrome: a fata morgana?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1271

7 January 2021

Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1271

7 January 2021

The use of receiver operating characteristic curves in biomedical informatics

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1271

7 January 2021

Current Treatment Options for the Metabolic Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1271

7 January 2021

Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1271

7 January 2021

Anti-inflammatory properties of drugs acting on the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1271

7 January 2021

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1271

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO1271

1 reference

18 August 2017

1 reference

PubMed ID

18580860